(PharmaNewsWire.Com, September 20, 2017 ) The Global Perfusion Systems Market is worth USD 0.99 billion in 2016 and estimated to grow at a CAGR of 3.4%, to reach USD 1.17 billion by 2021. The global Perfusion Systems market is developing at an exceptionally quick pace.
Cardiac perfusion systems were used to momentarily replace the functions of the heart during cardiac surgeries. The cardiac perfusion system market is broadly segmented into oxygenation systems, autotransfusion systems, hemoconcentrators, heat transfer systems, tubings, reservoirs, heart-lung machines, myocardial protection systems, arterial filters, blood monitoring systems, and cannulae, and others.
The crucial factor driving the growth of this market is increasing number of cardiac surgeries. Growing prevalence of cardiac and lung diseases in developed as well as developing further propels the growth of this market. Though, inadequate number of well-trained surgeons in emerging nations, unstable reimbursement policies, and stiff competition from local players with low cost products are hinders the growth of this market.
The Global market for Perfusion Systems is segmented on the basis of type, component, technique and region. Based on component, the market is segmented into Heart-lung Machines, Perfusion Pumps, Oxygenators, Monitoring Systems, Cannulas, and Other Components. Based on Type, the market is segmented into Bioreactor Perfusion Systems, Microfluidic Perfusion Systems, Gravity/Pressure-driven Perfusion Systems, and Small-mammal Organ Perfusion Systems. The bioreactor perfusion systems segment holds the major share of the perfusion systems market in 2016 and is projected to record the highest CAGR during the forecast period. Based on technique, the market is segmented into Hypothermic Machine Perfusion Systems, and Normothermic Machine Perfusion Systems.
Geographically, the Perfusion Systems market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East Asia. North America is estimated to constitute the largest share in this market, while the Asia Pacific region is expected to witness the fastest growth and overtake North America, being the second largest shareholder for the market during the forecast period.
Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), XENIOS AG (Germany) , Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.)are the leaders in the global Perfusion Systems market.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
